The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s popular weight-loss drug Wegovy to treat a serious form of fatty liver disease.
This article was originally published on MedicalXpress.com
FDA approves Wegovy to treat serious liver disease
You may also be interested in:
The Latest
Setting Boundaries: Nurturing a Healthy Partnership
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
The Latest
Microneedling Services in Edmonton: Benefits, Treatment Cost, and How It Works
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
The Latest
PetVet Dx Revolutionizes Wildlife Conservation with AI and Molecular Diagnostics to Combat Incurable CWD in Deer and Elk
Chronic wasting disease (CWD), a devastating prion illness that affects North American cervids like deer and elk, poses a grave threat to their well-being and conservation efforts. Furthermore, it presents a potential risk of human […]
Read More:
-
Making a smoothie, going for an evening walk, or having empathy for a loved one are all examples of executive functions that are controlled by [...]
-
A recent systematic review and meta-analysis conducted by researchers from the Research Institute of the McGill University Health Center (The Institute) and published in eClinicalMedicine [...]
-
With parents and teachers preparing for the return to classroom routines, Brock experts say fostering students’ physical and mental health is key for maximum learning [...]
